AUS
NZ
UK
CA
USA
IND
Healthcare
Fennec Pharmaceuticals (TSX:FRX) Experiences Slight Stock Decline
December 13, 2024 07:34 AM EST| By Team Kalkine MediaHighlights,Fennec Pharmaceuticals shows slight decline in stock price.,Insider activity includes purchase of shares by a Senior Officer.,The company focuses on pediatric cancer treatments, with a key product aimed at preventing platinum-induced ototo...
Kovo HealthTech's Strategic Fundraising Initiatives To Drive Growth
December 13, 2024 01:24 AM EST| By Team Kalkine MediaHighlights,Kovo,HealthTech launches a private placement to raise funds.,A concurrent offering focuses on corporate operational needs.,Both initiatives align with the company's growth strategy.,Kovo HealthTech Corporation,(TSXV:KOVO),, a healthcare te...
Knight Therapeutics (TSX: GUD) Receives Regulatory Approval for TAVALISSE® in Mexico for Treatment of Chronic ITP
December 12, 2024 09:19 AM EST| By Team Kalkine MediaHighlights,Grupo Biotoscana de Especialidad S.A. de C.V., has received regulatory approval from COFEPRIS for TAVALISSE® (fostamatinib disodium hexahydrate).,The approval is for the treatment of thrombocytopenia in adult patients with chronic immune t...
How Medicus Pharma Is Redefining SCC Treatment for Horses with D-MNA
December 12, 2024 08:13 AM EST| By Team Kalkine MediaHighlights:,Medicus Pharma Ltd.has received Minor Use in Major Species Designation (MUMS) from the FDA for its Doxorubicin-containing microneedle array (D-MNA) to treat equine squamous cell carcinoma.,The MUMS designation allows the company an exclus...
What’s Driving Insider Activity at Dentalcorp Holdings?
December 12, 2024 07:45 AM EST| By Team Kalkine MediaHighlights:,Insider activity at Dentalcorp Holdings Ltd. indicates a net buying trend over the past year.,The stock has seen insiders purchasing more shares than they have sold.,Such transactions may provide some insight into the company’s internal p...
BriaCell Therapeutics Announces Public Offering To Advance Cancer Immunotherapies
December 12, 2024 02:21 AM EST| By Team Kalkine MediaHighlights:,BriaCell,Therapeutics has announced a $5.5 million public offering.,The offering includes common shares and,warrants,to purchase,additional,shares.,Funds will support working capital and the development of cancer therapies.,BriaCell Thera...
Why Is Jazz Pharmaceuticals Attracting Major Moves by Institutional Funds?
December 10, 2024 06:06 AM EST| By Team Kalkine MediaHighlights,Two Sigma Advisers LP has significantly increased its holdings in Jazz Pharmaceuticals.,The firm now possesses a substantial number of Jazz Pharmaceuticals' shares, reflecting its active role in the sector.,The valuation of Two Sigma's hol...
Why Is DexCom Facing Challenges Despite Its Leadership in Diabetes Care?
December 10, 2024 05:43 AM EST| By Team Kalkine MediaHighlights,DexCom, Inc. operates in the medical devices sector, specializing in continuous glucose monitoring systems.,The company is recognized for its innovative technology and user-friendly design in diabetes management.,DexCom integrates its devi...
How Does Cancer Impact Financial Stability in Canadian Households?
December 09, 2024 05:27 AM EST| By Team Kalkine MediaHighlights,Cancer diagnosis leads to significant financial strain for patients and caregivers in Canada.,The economic burden on individuals and the healthcare system is substantial and growing.,Lower-income households and remote communities are dispr...
WELL Health Technologies Expands M&A Efforts Amid Revenue Growth
December 06, 2024 08:45 AM EST| By Team Kalkine MediaHighlights,WELL Health reports significant growth in quarterly revenue.,Earnings challenges and interest coverage issues,remain,key concerns.,Active M&A pipeline reflects focus on expanding services.,WELL Health Technologies,(TSX:WELL),, a prominent...
What Does Fountain Asset’s New Stock Option Plan Signal?
December 06, 2024 08:39 AM EST| By Team Kalkine MediaHighlights,Board approval for granting incentive stock options to directors and officers,Stock options exercisable at a price of five cents per share,Options set to expire in December two thousand twenty-nine,Fountain Asset Corp.,(TSXV:FA),has made a...
Is Medexus Pharmaceuticals Heading Toward Uncertainty?
December 05, 2024 06:30 AM EST| By Team Kalkine MediaHighlights,Significant rise in share price following a period of volatility,Valuation exceeds the average within the Canadian market,Earnings trends show a decline amidst sector-wide growth,Medexus Pharmaceuticals,(TSX:MDP),operates within the dynami...
Is Scancell’s Funding Move a Sign of Trouble?
December 05, 2024 04:00 AM EST| By Team Kalkine MediaHighlights,Scancell Holdings announces a funding initiative to support clinical programs.,Funds will enhance cancer immunotherapy projects targeting melanoma and renal cell carcinoma.,The company maintains substantial cash reserves and anticipates ad...
Why Is Profound Medical's Stock Struggling to Gain Momentum?
December 04, 2024 05:32 AM EST| By Team Kalkine MediaHighlights,Profound Medical Corp. operates within the medical technology sector.,The company's stock price experienced a slight increase during trading on Tuesday.,The daily trading volume remained stable compared to the average.,Profound Medical Cor...
What’s Behind Neovasc’s Surprising Trading Volume Drop?
December 04, 2024 03:24 AM EST| By Team Kalkine MediaHighlights,Neovasc Inc. operates in the medical device sector, specializing in innovative cardiovascular solutions.,The stock price for Neovasc Inc. recently experienced a slight rise during mid-day trading, reflecting its resilience in the healthcar...
Why Is Satellos Bioscience Making Headlines at a Key Summit?
December 03, 2024 10:29 AM EST| By Team Kalkine MediaHighlights,Satellos Bioscience Inc. operates in the biotechnology sector, focusing on rare diseases.,The company recently announced participation in a prestigious summit in New York City.,Shares of,(TSX:MSCL),remain steady, reflecting ongoing develop...
What Challenges Could Kane Biotech Face With This Offering?
December 03, 2024 09:51 AM EST| By Team Kalkine MediaHighlights,Kane Biotech operates in the biotechnology sector, focusing on innovative healthcare solutions.,Announces a private placement of common shares to fund operational and commercial growth.,The placement is subject to regulatory approval, with...
Why Is Medicus Pharma's Study Raising Global Concerns?
December 02, 2024 09:49 AM EST| By Team Kalkine MediaHighlights,Medicus Pharma collaborates with Swanielle to explore expanding its Basal Cell Carcinoma clinical study into Southeast Asia.,The current Phase 2 trial evaluates the efficacy of D-MNA at two dose levels through a randomized, double-blind, p...
Why Is Hamilton Thorne Delisting from the TSX?
November 29, 2024 01:25 PM EST| By Team Kalkine MediaHighlights,Hamilton Thorne finalized a going-private transaction with Cradle Acquisition ULC, overseen by Astorg.,All issued common shares were purchased at a predetermined value, with exceptions for specific stakeholders.,Hamilton Thorne shares will...
What’s Behind the Surge in WELL Health Shares?
November 29, 2024 11:17 AM EST| By Team Kalkine MediaHighlights,WELL Health Technologies Corp. operates in the healthcare technology sector, focusing on digital health solutions and clinical services.,The stock has recently shown significant performance growth over the past month and year.,WELL Health'...
